Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid

被引：13

作者：

Hofbauer, LC ^{[1
]}

Cepok, S

Hemmer, B

机构：

[1] Univ Marburg, Dept Med, Div Gastroenterol Endocrinol & Metab, D-35033 Marburg, Germany

[2] Univ Marburg, Dept Neurol, Marburg, Germany

[3] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany

来源：

ACTA NEUROPATHOLOGICA | 2004年 / 107卷 / 06期

关键词：

D O I：

10.1007/s00401-004-0854-y

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：575 / 577

页数：3

共 13 条

[1] Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis [J].

Cepok, S ;

Jacobsen, M ;

Schock, S ;

Omer, B ;

Jaekel, S ;

Böddeker, I ;

Oertel, WH ;

Sommer, N ;

Hemmer, B .

BRAIN, 2001, 124 :2169-2176

[2] Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL [J].

Emery, JG ;

McDonnell, P ;

Burke, MB ;

Deen, KC ;

Lyn, S ;

Silverman, C ;

Dul, E ;

Appelbaum, ER ;

Eichman, C ;

DiPrinzio, R ;

Dodds, RA ;

James, IE ;

Rosenberg, M ;

Lee, JC ;

Young, PR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14363-14367

[3] Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland [J].

Hofbauer, LC ;

Kluger, S ;

Kühne, CA ;

Dunstan, CR ;

Burchert, A ;

Schoppet, M ;

Zielke, A ;

Heufelder, AE .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 86 (04) :642-650

[4] Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand [J].

Kong, YY ;

Feïge, U ;

Sarosi, I ;

Bolon, B ;

Tafuri, A ;

Morony, S ;

Capparelli, C ;

Li, J ;

Elliott, R ;

McCabe, S ;

Wong, T ;

Campagnuolo, G ;

Moran, E ;

Bogoch, ER ;

Van, G ;

Nguyen, LT ;

Ohashi, PS ;

Lacey, DL ;

Fish, E ;

Boyle, WJ ;

Penninger, JM .

NATURE, 1999, 402 (6759) :304-309

[5] Osteoprotegerin ligand: a regulator of immune responses and bone physiology [J].

Kong, YY ;

Boyle, WJ ;

Penninger, JM .

IMMUNOLOGY TODAY, 2000, 21 (10) :495-502

[6]

Martin-Villalba A, 1999, J NEUROSCI, V19, P3809

[7] Expression and functional activity of osteoprotegerin in human malignant gliomas [J].

Naumann, U ;

Wick, W ;

Beschorner, R ;

Meyermann, R ;

Weller, M .

ACTA NEUROPATHOLOGICA, 2004, 107 (01) :17-22

[8] Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression [J].

Pearse, RN ;

Sordillo, EM ;

Yaccoby, S ;

Wong, BR ;

Liau, DF ;

Colman, N ;

Michaeli, J ;

Epstein, J ;

Choi, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11581-11586

[9]

ROWNER WS, 2001, J CLIN ENDOCR METAB, V86, P631

[10] Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].

Simonet, WS ;

Lacey, DL ;

Dunstan, CR ;

Kelley, M ;

Chang, MS ;

Luthy, R ;

Nguyen, HQ ;

Wooden, S ;

Bennett, L ;

Boone, T ;

Shimamoto, G ;

DeRose, M ;

Elliott, R ;

Colombero, A ;

Tan, HL ;

Trail, G ;

Sullivan, J ;

Davy, E ;

Bucay, N ;

RenshawGegg, L ;

Hughes, TM ;

Hill, D ;

Pattison, W ;

Campbell, P ;

Sander, S ;

Van, G ;

Tarpley, J ;

Derby, P ;

Lee, R ;

Boyle, WJ .

CELL, 1997, 89 (02) :309-319

← 1 2 →